What's not included in the quote — exosome IV in Myeongdong

The pricing structure for exosome IV in Myeongdong is rarely the figure quoted on the homepage. The homepage figure is the headline price for the exosome product itself — the vial cost, occasionally bundled with the basic professional fee — and almost never includes the full set of line items the patient actually pays at the chair. The disclosure norms across Myeongdong's dermatology corridor are inconsistent — a small minority of clinics quote an itemised total in advance on the pre-trip LINE thread, the majority quote the headline price and add line items at the chair, a small minority add line items with no transparent rationale. I have watched this line-item accumulation happen perhaps fifteen or twenty times across my reporting work, and the patterns are stable enough to write down. This page names the line items the prospective patient should ask about in advance, the typical price ranges where I have observed them, and the disclosure markers that signal a clinic that will or will not surprise the patient at checkout. The intent is not to police pricing but to make it legible so the patient can compare clearly across the corridor.

The IV bag itself — the line item the headline price often excludes

The headline price for an exosome IV protocol typically refers to the exosome vials themselves — the regenerative payload — not the carrier infusion that delivers them. The IV bag (typically a 250ml or 500ml normal saline or buffered isotonic solution) is a separate line item in many Myeongdong clinics, priced anywhere from 20,000 to 50,000 KRW depending on the carrier volume and the brand of saline used. A small minority of clinics include the IV bag in the headline price; the majority list it separately. The prospective patient should ask on the pre-trip LINE thread whether the headline price includes the carrier infusion, and a serious coordinator answers the question without hesitation. A coordinator who pivots to the price-list PDF without addressing the carrier-bag question directly is signalling that the line item will appear at the chair without further notice. The line item is not enormous in isolation, but it sets the disclosure tone for the rest of the visit.

IV port placement — the licensed fee that's sometimes a separate line

The IV port placement is the moment of clinical risk in the protocol and is performed by a licensed nursing professional or by the treating physician. The placement fee is typically 30,000 to 80,000 KRW and is sometimes — but not always — included in the headline price. The variation across clinics is not arbitrary; clinics that bill the placement separately often do so because the placement is performed by a physician rather than a nurse, with the physician's fee structure billed in line. Other clinics absorb the placement into the headline price as part of the bundled protocol. The question for the prospective patient is which structure their clinic uses, and the answer should be returned in writing on the LINE thread rather than verbally at the chair. The licensure of the placement professional is a question I would ask in the same exchange — the clinic-vetting checklist covers it in detail.

B-complex, vitamin C, glutathione — the add-on infusions that aren't add-ons

Many Myeongdong dermatology clinics offer B-complex, vitamin C, or glutathione add-on infusions alongside the exosome IV — sometimes presented at the chair as 'recommended' rather than as discretionary, sometimes priced at 80,000 to 200,000 KRW per add-on. The clinical rationale for these add-ons in conjunction with exosome IV is, in my reading of the published literature, marginal at best — they may produce some adjacent benefit in hydration or antioxidant load, but they do not materially enhance the exosome protocol itself. A serious clinic discloses on the pre-trip LINE thread whether the add-ons are included, optional, or recommended-but-billed-separately. A tourist-calibrated clinic introduces the add-ons at the chair with the patient already cannulated and the discussion happening across a saline line. The structural pressure of that conversation is the pressure the prospective patient should anticipate in advance and decline politely before the IV begins.

Microneedling — bundled with the IV or billed separately

The microneedling component is sometimes bundled with the exosome IV in the headline price and sometimes billed as a separate session at 150,000 to 350,000 KRW depending on depth, zonal coverage, and whether topical exosome is applied. The bundling decision is a clinical and pricing choice; the patient should know which structure applies before booking. A serious clinic specifies it on the LINE thread; a tourist-calibrated clinic clarifies at the chair after the IV portion has been paid. The protocol page covers the clinical rationale for the sequencing — the pricing structure tends to align with the sequencing logic the clinic uses.

Consultation fees — the line item that should be transparent

Some Myeongdong clinics charge a separate consultation fee — typically 50,000 to 150,000 KRW — that is sometimes credited toward the procedure if the patient proceeds, sometimes not. The credit-back arrangement is a marker of clinic seriousness about the consultation as a substantive clinical event rather than a sales conversation. The clinics that credit the consultation fee back are the clinics that view the consultation as part of the protocol; the clinics that do not are the clinics that view it as a separate revenue stream. Neither structure is wrong, but the structure should be disclosed in advance on the pre-trip thread, in writing, with the credit-back conditions specified. A patient who arrives at the chair without knowing the consultation fee structure has been failed by the disclosure norms of that clinic.

Topical preparations and post-procedure recovery products

Many Myeongdong clinics include a topical preparation in the microneedling protocol — a calming serum, regenerative essence, or barrier-repair cream applied immediately post-treatment — sometimes bundled, sometimes billed separately at 50,000 to 150,000 KRW. Clinics that bundle tend to use their own house formulation or a vendor product purchased in bulk; clinics that bill separately tend to be offering a higher-end branded product the patient can take home. The take-home component is the line item that most frequently surprises the patient — a recovery product kit positioned at checkout, priced at 100,000 to 300,000 KRW, presented as recommended rather than discretionary. The same structural pressure as the B-complex conversation applies; the same decline-in-advance applies.

Photo documentation, before-and-after sessions, and the four-week follow-up

Some clinics include the pre-procedure photo documentation, the immediate post-procedure photo, and the four-week follow-up photo in the headline price; some clinics bill these as separate documentation fees at 30,000 to 100,000 KRW per session. The documentation is clinically valuable — it allows the senior physician to assess the four-week regenerative outcome against the pre-treatment baseline — and the clinics that include it in the bundled price tend to be the clinics that take the four-week follow-up seriously. The clinics that bill separately tend to be the clinics that produce the photos as a marketing artifact rather than a clinical record. The pricing structure is itself diagnostic of the clinic's seriousness about the post-trip phase of the protocol.

International-patient surcharges — the line item that should not exist

I want to name one specific failure mode the prospective patient should refuse to accept: the international-patient surcharge some Myeongdong clinics add at the chair side, justified variously as 'translation fee', 'foreigner-handling fee', or 'service charge for international patients'. The surcharge is not a regulated category in Korean healthcare pricing and is, in my reading, indistinguishable from a markup applied on the assumption the international patient will not push back. Serious clinics catering to international patients do not apply this surcharge — the international-patient workflow is built into the operating model and not billed back as a line item. A clinic that applies the surcharge is signalling its tourist-calibration; the patient should decline politely and reference the KHIDI facilitator framework if the clinic insists. The KHIDI-registered facilitator the publisher network operates under (A-2026-04-02-06873) does not pass through surcharges of this kind.

Currency, exchange rate, and payment method

Pricing in Myeongdong dermatology clinics is denominated in Korean Won (KRW), and the conversion to JPY for Japanese patients happens at the bank-of-Korea midmarket rate or at a clinic-specified rate that may include a small spread. A serious clinic discloses the rate they will apply on the pre-trip thread; a tourist-calibrated clinic applies a rate at checkout without disclosure. Payment methods accepted typically include international Visa and Mastercard, JCB for Japanese patients, and bank transfer in JPY or KRW. The patient should confirm the payment method and the applied exchange rate in advance, and should refuse to pay through cash channels that do not produce a receipt. The receipt is not optional — it is the documentation that may be required for any post-trip adverse-event reporting or for any subsequent insurance interaction in Japan.

“The itemised quote is the diagnostic; the resistance is the warning.”

Saki Watanabe, Seoul notebook

Frequently asked questions

What is the typical total cost of an exosome IV plus microneedling protocol in Myeongdong?

The total cost across the line items above typically lands between 600,000 and 1,500,000 KRW (approximately 65,000 to 165,000 JPY at recent exchange rates) for a single-session protocol. The variance reflects the exosome product brand, the inclusion or exclusion of microneedling, the carrier-bag size, and the add-on infusions. A serious clinic produces an itemised total in this range with line items specified; a tourist-calibrated clinic quotes the lower end and bills toward the upper end at the chair.

Is it appropriate to ask for an itemised quote in writing?

Yes — and a serious clinic returns the itemised quote on the LINE thread without hesitation. A clinic that resists the itemised quote is signalling that the line items will accumulate at the chair without prior disclosure. The itemised quote is the diagnostic; the resistance is the warning.

Should I expect to pay a consultation fee separately?

Some clinics charge a consultation fee of 50,000 to 150,000 KRW that may or may not be credited toward the procedure if the patient proceeds. The credit-back structure should be disclosed in advance. A clinic that does not disclose the consultation fee structure before the consultation is signalling something.

Are the B-complex or glutathione add-ons clinically necessary?

Not in my reading of the published literature on exosome IV protocols. The add-ons may produce some adjacent benefit but do not materially enhance the regenerative effect of the exosome itself. A patient who wishes to decline the add-ons should decline them in advance on the LINE thread, before the chair conversation.

Can the international-patient surcharge be refused?

Yes — the surcharge is not a regulated pricing category in Korean healthcare. The KHIDI-registered facilitator framework does not pass through surcharges of this kind. A patient who encounters the surcharge at the chair side should decline it politely and reference the facilitator framework. A clinic that insists is a clinic the patient may wish to reconsider.

What about cash discounts?

Some clinics offer a small cash discount (typically three to five percent) in exchange for payment in physical cash rather than by card. The discount is occasionally legitimate but is sometimes offered to avoid producing a receipt. The patient should refuse any payment that does not produce a formal receipt, regardless of the discount offered. The receipt may be required for adverse-event documentation or for post-trip insurance interaction.

Are there package discounts for multi-session protocols?

Some clinics offer package pricing for two- or three-session protocols across consecutive trips, typically discounting the per-session price by ten to twenty percent in exchange for upfront commitment. The package is reasonable for patients with a clear multi-session indication. The package is unreasonable for patients without that indication, in which case the upfront commitment is functioning as a sales lever rather than a clinical recommendation.

Does the publisher network handle payment?

No — payment is between the patient and the treating clinic directly. The KHIDI-registered facilitator framework supports coordination, interpretation, and documentation; the financial transaction remains with the clinic. The pricing transparency this page advocates for is therefore a question to ask the clinic, not a service the facilitator performs.